PBH
Prestige Consumer Healthcare Inc.
Key Financials
Net Income
$190.3M
↓ 11.3%
Revenue
$1.1B
↓ 4.3%
Operating Income
$309.4M
↓ 8.1%
Gross Profit
$595.6M
↓ 6.1%
Total Liabilities
$1.6B
↑ 2.5%
EPS (Diluted)
$3.91
↓ 8.9%
Shareholders' Equity
$1.9B
↑ 2.9%
Total Assets
$3.5B
↑ 2.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K/A | 6/30/2026 | View on SEC |
| ARS | 6/29/2026 | View on SEC |
| DEF 14A | 6/29/2026 | View on SEC |
| 8-K | 6/16/2026 | View on SEC |
| 10-K | 5/14/2026 | View on SEC |
| 4/A | 5/14/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| 4 | 5/12/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PBH |
| Company Name | Prestige Consumer Healthcare Inc. |
| CIK | 1295947 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| Phone | (914) 524-6800 |